发文分析
近年国家/地区发文量统计
| 国家/地区 | 数量 |
|---|---|
| USA | 446 |
| Turkey | 108 |
| Canada | 85 |
| France | 30 |
| Spain | 30 |
| Japan | 28 |
| Australia | 24 |
| England | 23 |
| Italy | 23 |
| Saudi Arabia | 17 |
近年机构发文量统计
| 机构 | 数量 |
|---|---|
| UNIVERSITY OF CALIFORNIA SYSTEM | 32 |
| UNIVERSITY OF HEALTH SCIENCES TURKEY | 22 |
| UNIVERSITY OF NORTH CAROLINA | 22 |
| UNIVERSITY OF TEXAS SYSTEM | 22 |
| ALBERTA HEALTH SERVICES (AHS) | 18 |
| OHIO STATE UNIVERSITY | 18 |
| EISENHOWER MED CTR | 17 |
| UNIVERSITY OF CALGARY | 17 |
| HACETTEPE UNIVERSITY | 16 |
| UNIVERSITY OF MICHIGAN SYSTEM | 16 |
近年文章引用他刊数据
| 文章名称 | 引用次数 |
|---|---|
| Tocilizumab for the management of immune mediated advers... | 54 |
| Osimertinib: A third-generation tyrosine kinase inhibito... | 13 |
| Demonstrating the value of the oncology pharmacist withi... | 12 |
| Pembrolizumab-induced myasthenia gravis: A fatal case re... | 11 |
| Adherence to oral chemotherapy: Challenges and opportuni... | 11 |
| Updates and novel treatments in urothelial carcinoma | 9 |
| Incidence of asparaginase-related hepatotoxicity, pancre... | 8 |
| Meta-analysis and indirect treatment comparison of lipeg... | 8 |
| Corticosteroids for the management of immune-related adv... | 7 |
| Late-onset Stevens-Johnson syndrome due to nivolumab use... | 7 |
近年被他刊引用数据
| 期刊名称 | 引用次数 |
|---|---|
| J ONCOL PHARM PRACT | 248 |
| AM J HEALTH-SYST PH | 24 |
| J ONCOL PRACT | 20 |
| SUPPORT CARE CANCER | 14 |
| CANCER CHEMOTH PHARM | 12 |
| FRONT PHARMACOL | 11 |
| ANN ONCOL | 9 |
| EXPERT OPIN DRUG MET | 9 |
| SEMIN ONCOL NURS | 9 |
| CANCERS | 8 |